HEADER TRANSFERASE/TRANSFERASE INIHIBITOR 19-JAN-17 5X02 TITLE CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR FF- TITLE 2 10101 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 564-710,762-958; COMPND 5 SYNONYM: FL CYTOKINE RECEPTOR,FETAL LIVER KINASE-2,FLK-2,FMS-LIKE COMPND 6 TYROSINE KINASE 3,FLT-3,STEM CELL TYROSINE KINASE 1,STK-1,FL CYTOKINE COMPND 7 RECEPTOR,FETAL LIVER KINASE-2,FLK-2,FMS-LIKE TYROSINE KINASE 3,FLT-3, COMPND 8 STEM CELL TYROSINE KINASE 1,STK-1; COMPND 9 EC: 2.7.10.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLT3, CD135, FLK2, STK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TYROSINE KINASE, TRANSFERASE, IRREVERSIBLE INHIBITOR COMPLEX, KINASE KEYWDS 2 CATALYTIC DOMAIN, TRANSFERASE-TRANSFERASE INIHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.FUJIKAWA,D.HIRANO,M.TAKASAKI,D.TERADA,S.HAGIWARA,S.-Y.PARK, AUTHOR 2 K.SUGIYAMA REVDAT 3 22-NOV-23 5X02 1 REMARK REVDAT 2 06-FEB-19 5X02 1 JRNL REVDAT 1 24-JAN-18 5X02 0 JRNL AUTH T.YAMAURA,T.NAKATANI,K.UDA,H.OGURA,W.SHIN,N.KUROKAWA, JRNL AUTH 2 K.SAITO,N.FUJIKAWA,T.DATE,M.TAKASAKI,D.TERADA,A.HIRAI, JRNL AUTH 3 A.AKASHI,F.CHEN,Y.ADACHI,Y.ISHIKAWA,F.HAYAKAWA,S.HAGIWARA, JRNL AUTH 4 T.NAOE,H.KIYOI JRNL TITL A NOVEL IRREVERSIBLE FLT3 INHIBITOR, FF-10101, SHOWS JRNL TITL 2 EXCELLENT EFFICACY AGAINST AML CELLS WITHFLT3MUTATIONS. JRNL REF BLOOD V. 131 426 2018 JRNL REFN ESSN 1528-0020 JRNL PMID 29187377 JRNL DOI 10.1182/BLOOD-2017-05-786657 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 19705 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5X02 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1300002691. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19769 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 14.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 57.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1RJB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2-2.4M NA/K PHOSPHATE, 0.1M CAPS REMARK 280 (PH6.7), 0.2M LITIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.77900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.99650 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.99650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 107.66850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.99650 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.99650 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 35.88950 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.99650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.99650 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 107.66850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.99650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.99650 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 35.88950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.77900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 561 REMARK 465 PRO A 562 REMARK 465 GLY A 563 REMARK 465 HIS A 564 REMARK 465 LYS A 565 REMARK 465 TYR A 566 REMARK 465 LYS A 567 REMARK 465 LYS A 568 REMARK 465 GLN A 569 REMARK 465 PHE A 570 REMARK 465 ARG A 571 REMARK 465 TYR A 572 REMARK 465 GLU A 763 REMARK 465 ASP A 764 REMARK 465 GLU A 765 REMARK 465 ILE A 766 REMARK 465 GLU A 767 REMARK 465 TYR A 768 REMARK 465 GLU A 769 REMARK 465 ASN A 770 REMARK 465 GLN A 771 REMARK 465 LYS A 772 REMARK 465 ARG A 773 REMARK 465 LEU A 774 REMARK 465 GLU A 775 REMARK 465 GLU A 776 REMARK 465 GLU A 777 REMARK 465 GLU A 778 REMARK 465 ASP A 779 REMARK 465 LEU A 780 REMARK 465 ASN A 781 REMARK 465 ALA A 948 REMARK 465 ASP A 949 REMARK 465 ALA A 950 REMARK 465 GLU A 951 REMARK 465 GLU A 952 REMARK 465 ALA A 953 REMARK 465 MET A 954 REMARK 465 TYR A 955 REMARK 465 GLN A 956 REMARK 465 ASN A 957 REMARK 465 VAL A 958 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 611 CB CG CD OE1 OE2 REMARK 470 LYS A 614 CB CG CD CE NZ REMARK 470 VAL A 637 CG1 CG2 REMARK 470 LYS A 647 CG CD CE NZ REMARK 470 ASP A 651 CB CG OD1 OD2 REMARK 470 GLU A 656 CG CD OE1 OE2 REMARK 470 LYS A 709 CD CE NZ REMARK 470 LYS A 823 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 633 -9.17 -146.87 REMARK 500 ALA A 650 79.37 -152.68 REMARK 500 LEU A 683 -65.87 -90.74 REMARK 500 SER A 684 49.63 -85.84 REMARK 500 ASP A 811 51.76 -150.00 REMARK 500 THR A 820 -163.81 -122.69 REMARK 500 ASP A 835 96.00 -60.66 REMARK 500 LEU A 943 41.19 -80.97 REMARK 500 GLN A 946 92.30 -68.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 837 SER A 838 149.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F6M A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1004 DBREF 5X02 A 564 710 UNP P36888 FLT3_HUMAN 564 710 DBREF 5X02 A 711 958 UNP P36888 FLT3_HUMAN 762 958 SEQADV 5X02 GLY A 561 UNP P36888 EXPRESSION TAG SEQADV 5X02 PRO A 562 UNP P36888 EXPRESSION TAG SEQADV 5X02 GLY A 563 UNP P36888 EXPRESSION TAG SEQRES 1 A 347 GLY PRO GLY HIS LYS TYR LYS LYS GLN PHE ARG TYR GLU SEQRES 2 A 347 SER GLN LEU GLN MET VAL GLN VAL THR GLY SER SER ASP SEQRES 3 A 347 ASN GLU TYR PHE TYR VAL ASP PHE ARG GLU TYR GLU TYR SEQRES 4 A 347 ASP LEU LYS TRP GLU PHE PRO ARG GLU ASN LEU GLU PHE SEQRES 5 A 347 GLY LYS VAL LEU GLY SER GLY ALA PHE GLY LYS VAL MET SEQRES 6 A 347 ASN ALA THR ALA TYR GLY ILE SER LYS THR GLY VAL SER SEQRES 7 A 347 ILE GLN VAL ALA VAL LYS MET LEU LYS GLU LYS ALA ASP SEQRES 8 A 347 SER SER GLU ARG GLU ALA LEU MET SER GLU LEU LYS MET SEQRES 9 A 347 MET THR GLN LEU GLY SER HIS GLU ASN ILE VAL ASN LEU SEQRES 10 A 347 LEU GLY ALA CYS THR LEU SER GLY PRO ILE TYR LEU ILE SEQRES 11 A 347 PHE GLU TYR CYS CYS TYR GLY ASP LEU LEU ASN TYR LEU SEQRES 12 A 347 ARG SER LYS ARG GLU LYS PHE SER GLU ASP GLU ILE GLU SEQRES 13 A 347 TYR GLU ASN GLN LYS ARG LEU GLU GLU GLU GLU ASP LEU SEQRES 14 A 347 ASN VAL LEU THR PHE GLU ASP LEU LEU CYS PHE ALA TYR SEQRES 15 A 347 GLN VAL ALA LYS GLY MET GLU PHE LEU GLU PHE LYS SER SEQRES 16 A 347 CYS VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 17 A 347 THR HIS GLY LYS VAL VAL LYS ILE CYS ASP PHE GLY LEU SEQRES 18 A 347 ALA ARG ASP ILE MET SER ASP SER ASN TYR VAL VAL ARG SEQRES 19 A 347 GLY ASN ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 20 A 347 SER LEU PHE GLU GLY ILE TYR THR ILE LYS SER ASP VAL SEQRES 21 A 347 TRP SER TYR GLY ILE LEU LEU TRP GLU ILE PHE SER LEU SEQRES 22 A 347 GLY VAL ASN PRO TYR PRO GLY ILE PRO VAL ASP ALA ASN SEQRES 23 A 347 PHE TYR LYS LEU ILE GLN ASN GLY PHE LYS MET ASP GLN SEQRES 24 A 347 PRO PHE TYR ALA THR GLU GLU ILE TYR ILE ILE MET GLN SEQRES 25 A 347 SER CYS TRP ALA PHE ASP SER ARG LYS ARG PRO SER PHE SEQRES 26 A 347 PRO ASN LEU THR SER PHE LEU GLY CYS GLN LEU ALA ASP SEQRES 27 A 347 ALA GLU GLU ALA MET TYR GLN ASN VAL HET F6M A1001 39 HET SO4 A1002 5 HET SO4 A1003 5 HET SO4 A1004 5 HETNAM F6M N-[(2S)-1-[5-[2-[(4-CYANOPHENYL)AMINO]-4-(PROPYLAMINO) HETNAM 2 F6M PYRIMIDIN-5-YL]PENT-4-YNYLAMINO]-1-OXIDANYLIDENE- HETNAM 3 F6M PROPAN-2-YL]-4-(DIMETHYLAMINO)-N-METHYL-BUT-2-ENAMIDE HETNAM SO4 SULFATE ION FORMUL 2 F6M C29 H38 N8 O2 FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 HOH *12(H2 O) HELIX 1 AA1 ASP A 593 TYR A 597 5 5 HELIX 2 AA2 ASP A 600 GLU A 604 5 5 HELIX 3 AA3 PRO A 606 GLU A 608 5 3 HELIX 4 AA4 ASP A 651 GLY A 669 1 19 HELIX 5 AA5 ASP A 698 SER A 705 1 8 HELIX 6 AA6 THR A 784 LYS A 805 1 22 HELIX 7 AA7 ALA A 813 ARG A 815 5 3 HELIX 8 AA8 HIS A 821 LYS A 823 5 3 HELIX 9 AA9 PRO A 851 MET A 855 5 5 HELIX 10 AB1 ALA A 856 GLY A 863 1 8 HELIX 11 AB2 THR A 866 PHE A 882 1 17 HELIX 12 AB3 ASP A 895 ASN A 904 1 10 HELIX 13 AB4 THR A 915 TRP A 926 1 12 HELIX 14 AB5 ASP A 929 ARG A 933 5 5 HELIX 15 AB6 SER A 935 LEU A 943 1 9 SHEET 1 AA1 3 TYR A 589 TYR A 591 0 SHEET 2 AA1 3 LEU A 576 VAL A 581 -1 N GLN A 580 O PHE A 590 SHEET 3 AA1 3 CYS A 807 HIS A 809 -1 O VAL A 808 N GLN A 577 SHEET 1 AA2 5 LEU A 610 GLY A 619 0 SHEET 2 AA2 5 GLY A 622 TYR A 630 -1 O THR A 628 N GLU A 611 SHEET 3 AA2 5 SER A 638 MET A 645 -1 O VAL A 641 N ALA A 627 SHEET 4 AA2 5 TYR A 688 GLU A 692 -1 O PHE A 691 N ALA A 642 SHEET 5 AA2 5 LEU A 677 CYS A 681 -1 N LEU A 678 O ILE A 690 SHEET 1 AA3 2 VAL A 817 THR A 820 0 SHEET 2 AA3 2 VAL A 824 ILE A 827 -1 O VAL A 824 N THR A 820 SHEET 1 AA4 2 VAL A 843 ARG A 845 0 SHEET 2 AA4 2 ALA A 848 LEU A 850 -1 O LEU A 850 N VAL A 843 LINK SG CYS A 695 C23 F6M A1001 1555 1555 1.62 SITE 1 AC1 15 LEU A 616 VAL A 624 ALA A 642 LYS A 644 SITE 2 AC1 15 VAL A 675 PHE A 691 GLU A 692 TYR A 693 SITE 3 AC1 15 CYS A 694 CYS A 695 TYR A 696 LEU A 818 SITE 4 AC1 15 HIS A 821 CYS A 828 ASP A 829 SITE 1 AC2 7 VAL A 592 TYR A 597 ARG A 704 ARG A 707 SITE 2 AC2 7 GLY A 885 VAL A 886 ASN A 887 SITE 1 AC3 4 GLN A 580 ARG A 704 ASN A 841 ASN A 887 SITE 1 AC4 7 GLU A 604 PHE A 605 ARG A 607 CYS A 681 SITE 2 AC4 7 LEU A 683 SER A 684 VAL A 844 CRYST1 81.993 81.993 143.558 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012196 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012196 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006966 0.00000